Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Choriocapillaris (CC) Analysis in Subjects with Intermediate Age-Related Macular Degeneration and Geographic Atrophy using SD and SS OCT Angiography
Author Affiliations & Notes
  • Hikmet Yucel
    Ocular Imaging Research and Reading Center, Sunnyvale, California, United States
  • Muhammad Sohail Halim
    Ophthalmology, Stanford University School of Medicine, Stanford, California, United States
  • Kholood Janjua
    Ophthalmology, Stanford University School of Medicine, Stanford, California, United States
  • Sean Baluyot
    Ocular Imaging Research and Reading Center, Sunnyvale, California, United States
  • Hugo Guzman
    Ocular Imaging Research and Reading Center, Sunnyvale, California, United States
  • Taffeta Yamaguchi
    Boehringer Ingelheim International GmbH, Ingelheim, Rheinland-Pfalz, Germany
  • Marieh Esmaeelpour
    Boehringer Ingelheim International GmbH, Ingelheim, Rheinland-Pfalz, Germany
  • Theodore Leng
    Ophthalmology, Stanford University School of Medicine, Stanford, California, United States
  • Diana V Do
    Ophthalmology, Stanford University School of Medicine, Stanford, California, United States
  • Yasir Jamal Sepah
    Ophthalmology, Stanford University School of Medicine, Stanford, California, United States
  • Footnotes
    Commercial Relationships   Hikmet Yucel None; Muhammad Sohail Halim None; Kholood Janjua None; Sean Baluyot None; Hugo Guzman None; Taffeta Yamaguchi 3. Boehringer Ingelheim International GmbH, Ingelheim, Rheinland-Pfalz, Germany, Code E (Employment); Marieh Esmaeelpour 3. Boehringer Ingelheim International GmbH, Ingelheim, Rheinland-Pfalz, Germany, Code E (Employment); Theodore Leng Alcon, BI, Astellas, Apellis, roche/genentech, Regeneron, protagonist, Nanoscope, Code C (Consultant/Contractor), Astellas, Code R (Recipient); Diana Do Regeneron, RegenX therapeutics, Genentech, Code R (Recipient); Yasir Jamal Sepah Kriya Therapeutics, BIPI, Code C (Consultant/Contractor), BIPI, Code R (Recipient)
  • Footnotes
    Support  External Collaborative Research grant Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI)
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 1405. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hikmet Yucel, Muhammad Sohail Halim, Kholood Janjua, Sean Baluyot, Hugo Guzman, Taffeta Yamaguchi, Marieh Esmaeelpour, Theodore Leng, Diana V Do, Yasir Jamal Sepah; Choriocapillaris (CC) Analysis in Subjects with Intermediate Age-Related Macular Degeneration and Geographic Atrophy using SD and SS OCT Angiography. Invest. Ophthalmol. Vis. Sci. 2024;65(7):1405.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To compare the vascular flow voids in CC of subjects with iAMD, GA, and age-matched controls.

Methods : Subjects with iAMD, GA and healthy controls were enrolled in a prospective observational study (The OREO Study). Subjects were assessed quarterly. OCTA images were obtained using Optovue AngioVue and Zeiss PlexElite. A 6mm x 6mm cube OCTA, centered on fovea, was obtained for each subject. CC, superficial, and avascular slab were extracted from the OCTA exams. To identify drusen, a slab of 5um at ISOS was also extracted. A custom MATLAB software was used for analysis. Big vessels identified from superficial slab, and drusen from the drusen slab were annotated in a semi-automatic manner where graders manually corrected the masks, if needed. These areas were excluded from the analysis. The rest of the image was analyzed to measure average pixel intensity. The pixels which were lower than 1 SD of the mean are identified as flow voids. The flow voids are then categorized based on size. For patients with GA, lesion and transition zone boundaries were imported from OCT and FAF and overlayed on CC OCTA following registration.

Results : 64 eyes imaged with both Optovue and PlexElite were analyzed. The mean flow void percent was 18.52 ± 0.80% and 15.49 ± 0.67% and the mean total number of flow voids was 6189.9 ± 171.4 vs 7213.1 ± 1297.1 for Optovue and PlexElite respectively. The mean change from baseline at week 24 for both devices is demonstrated in Table 1. Larger flow voids (800mm2), assessed using Optovue OCTA, increased in both iAMD and GA lesion compared to age-matched controls (Figure 1A-1B). Mean change in total void percent area remained similar over 36 weeks with a mean change of 0.15% in iAMD vs -0.06% in controls. Eyes with GA demonstrated a mean change in total void percent of 17.0% for GA, 17.8% for TZ, 14.4% for healthy retina, compared to -12.0 for age-matched control eyes over 12 weeks.

Conclusions : SD OCT can be reliably used to assess changes in CC. Larger flow voids tend to increase in number in areas of GA. Eyes with iAMD demonstrate similar trends in changes in flow voids compared to controls.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

Mean change in CC attributes at Week 24 compared to baseline for Optovue vs PlexElite OCTA

Mean change in CC attributes at Week 24 compared to baseline for Optovue vs PlexElite OCTA

 

Figure 1A, 1B: Change from baseline in Flow Voids in Subjects with iAMD and GA compared to Controls by flow void size, respectively.

Figure 1A, 1B: Change from baseline in Flow Voids in Subjects with iAMD and GA compared to Controls by flow void size, respectively.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×